Latest filing published 03 Sept 2021 for AbCellera Biologics Inc., €12.5M. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Ester Falconer in AbCellera Biologics Inc., where the filings describe the role as senior executive. Over a trading history stretching from 9 June 2021 to 1 September 2021, the count stands at 2 filings.
Every open-market trade on record is a sale: 1 sale worth €20.9M. Besides market trades, the filings include 1 option exercise.
The record was last updated on 3 September 2021 with an option exercise (€12.5M) in AbCellera Biologics Inc. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations